Your browser doesn't support javascript.
loading
Secukinumab after anti-tumour necrosis factor-α therapy: a phase III study in active rheumatoid arthritis.
Dokoupilová, E; Aelion, J; Takeuchi, T; Malavolta, N; Sfikakis, P P; Wang, Y; Rohrer, S; Richards, H B.
Afiliação
  • Dokoupilová E; a Medical Plus, s.r.o ., Uherske Hradiste , Czech Republic.
  • Aelion J; b Jackson Arthritis Clinic, and Health Science Center , University of Tennessee , Memphis , TN , USA.
  • Takeuchi T; c Division of Rheumatology , Keio University School of Medicine , Tokyo , Japan.
  • Malavolta N; d Department of Medical and Surgical Sciences, Division of Internal Medicine , St Orsola-Malpighi Hospital, University of Bologna , Bologna , Italy.
  • Sfikakis PP; e Joint Academic Rheumatology Program , National and Kapodistrian University of Athens, School of Medicine , Athens , Greece.
  • Wang Y; f Novartis Pharmaceuticals Corporation , East Hanover , NJ , USA.
  • Rohrer S; g Novartis Pharma AG , Basel , Switzerland.
  • Richards HB; g Novartis Pharma AG , Basel , Switzerland.
Scand J Rheumatol ; 47(4): 276-281, 2018 07.
Article em En | MEDLINE | ID: mdl-29458278
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Anticorpos Monoclonais Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Scand J Rheumatol Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Anticorpos Monoclonais Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Scand J Rheumatol Ano de publicação: 2018 Tipo de documento: Article